
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Centrally acting anticholinergic drug trihexyphenidyl is highly effective in reducing nightmares associated with postātraumatic stress disorder
Katsumasa Sogo, Masanobu Sogo, Yoshie Okawa
Brain and Behavior (2021) Vol. 11, Iss. 6
Open Access | Times Cited: 6
Katsumasa Sogo, Masanobu Sogo, Yoshie Okawa
Brain and Behavior (2021) Vol. 11, Iss. 6
Open Access | Times Cited: 6
Showing 6 citing articles:
Genetically regulated multi-omics study for symptom clusters of posttraumatic stress disorder highlights pleiotropy with hematologic and cardio-metabolic traits
Gita A. Pathak, Kritika Singh, Frank R. Wendt, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 3, pp. 1394-1404
Open Access | Times Cited: 29
Gita A. Pathak, Kritika Singh, Frank R. Wendt, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 3, pp. 1394-1404
Open Access | Times Cited: 29
Pharmacological Management of Nightmares Associated with Posttraumatic Stress Disorder
Christoff Geldenhuys, Leigh Luella van den Heuvel, Petrus Steyn, et al.
CNS Drugs (2022) Vol. 36, Iss. 7, pp. 721-737
Closed Access | Times Cited: 18
Christoff Geldenhuys, Leigh Luella van den Heuvel, Petrus Steyn, et al.
CNS Drugs (2022) Vol. 36, Iss. 7, pp. 721-737
Closed Access | Times Cited: 18
The treatment of post-traumatic nightmares requires more attention
Esther Kim, Connie Kang
Drugs & Therapy Perspectives (2023) Vol. 39, Iss. 4, pp. 125-130
Closed Access | Times Cited: 2
Esther Kim, Connie Kang
Drugs & Therapy Perspectives (2023) Vol. 39, Iss. 4, pp. 125-130
Closed Access | Times Cited: 2
Muscarinic receptor drug trihexyphenidyl can alter growth of mesenchymal glioblastoma in vivo
Renfei Du, Ahmed Yousuf Sanin, Wenjie Shi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Renfei Du, Ahmed Yousuf Sanin, Wenjie Shi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Modern Russian drugs for the treatment of neurodegenerative diseases
Elena V. Galitsyna, Natalya Alexandrovna Ulyakina, Alexander B. Gusev
Reviews on Clinical Pharmacology and Drug Therapy (2024)
Closed Access
Elena V. Galitsyna, Natalya Alexandrovna Ulyakina, Alexander B. Gusev
Reviews on Clinical Pharmacology and Drug Therapy (2024)
Closed Access